These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16466334)

  • 1. Nesiritide therapy in a term neonate with renal disease.
    Moffett BS; Jefferies JL; Rossano J; Towbin JA
    Pharmacotherapy; 2006 Feb; 26(2):281-4. PubMed ID: 16466334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects and safety of nesiritide in neonates with heart failure.
    Simsic JM; Mahle WT; Cuadrado A; Kirshbom PM; Maher KO
    J Intensive Care Med; 2008; 23(6):389-95. PubMed ID: 18805856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a large nesiritide bolus dose in a pediatric patient: case report and review of nesiritide use in pediatrics.
    Moffett BS; Jefferies JL; Price JF; Clunie S; Denfield S; Dreyer WJ; Towbin JA
    Pharmacotherapy; 2006 Feb; 26(2):277-80. PubMed ID: 16466333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary experience with nesiritide in pediatric patients less than 12 months of age.
    Ryan A; Rosen DA; Tobias JD
    J Intensive Care Med; 2008; 23(5):321-8. PubMed ID: 18603536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of nesiritide in pediatric heart failure.
    Jefferies JL; Price JF; Denfield SW; Chang AC; Dreyer WJ; McMahon CJ; Grenier MA; Clunie SK; Thomas A; Moffett BS; Wann TS; Smith EO; Towbin JA
    J Card Fail; 2007 Sep; 13(7):541-8. PubMed ID: 17826644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nesiritide during extracorporeal membrane oxygenation.
    Smith T; Rosen DA; Russo P; Berkenbosch JW; Gustafson RA; Siu BL; Rosen KR; Tobias JD
    Paediatr Anaesth; 2005 Feb; 15(2):152-7. PubMed ID: 15675934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative effects and safety of nesiritide following cardiac surgery in children.
    Simsic JM; Scheurer M; Tobias JD; Berkenbosch J; Schechter W; Madera F; Weinstein S; Michler RE
    J Intensive Care Med; 2006; 21(1):22-6. PubMed ID: 16698741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nesiritide as bridge to multi-organ transplantation: a case report.
    Cochrane AB; Fedson SE; Cronin DC
    Transplant Proc; 2007; 39(1):308-10. PubMed ID: 17275531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
    Schwarz ER; Najam S; Akel R; Sulimanjee N; Bionat S; Rosanio S
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between nesiritide and a heparin-coated pulmonary artery line during an infusion for decompensated heart failure.
    Baroletti SA; Wahlstrom HD
    Pharmacotherapy; 2004 Nov; 24(11):1634-7. PubMed ID: 15537565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience with nesiritide in the pediatric population.
    Marshall J; Berkenbosch JW; Russo P; Tobias JD
    J Intensive Care Med; 2004; 19(3):164-70. PubMed ID: 15154997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nesiritide: harmful or harmless?
    Dorsch MP; Rodgers JE
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective evaluation of nesiritide in the treatment of pediatric heart failure.
    Jefferies JL; Denfield SW; Price JF; Dreyer WJ; McMahon CJ; Grenier MA; Kim JJ; Dimas VV; Clunie SK; Moffett BS; Chang AC; Wann TI; Smith EO; Towbin JA
    Pediatr Cardiol; 2006; 27(4):402-7. PubMed ID: 16830089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nesiritide use in pediatric patients with congestive heart failure.
    Feingold B; Law YM
    J Heart Lung Transplant; 2004 Dec; 23(12):1455-9. PubMed ID: 15607680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nesiritide: past, present, and future.
    Burger AJ; Burger MR
    Minerva Cardioangiol; 2005 Dec; 53(6):509-22. PubMed ID: 16333235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients.
    Brackbill ML; Stam MD; Schuller-Williams RV; Dhavle AA
    Ann Pharmacother; 2007 Mar; 41(3):427-32. PubMed ID: 17311834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of nesiritide in patients after coronary artery bypass surgery induces brisk diuresis.
    Benharash P; Omari B
    Am Surg; 2005 Sep; 71(9):794-6. PubMed ID: 16468521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
    Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P
    Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.